These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6734694)

  • 21. [Effect of 3-month treatment with propranolol, oxprenolol, metoprolol and pindolol on plasma lipids and lipoproteins in patients with primary arterial hypertension].
    Sznajderman M; Cybulska I; Niegowska J; Zawadzki Z; Sznajderman M
    Kardiol Pol; 1985; 28(7):489-99. PubMed ID: 2868145
    [No Abstract]   [Full Text] [Related]  

  • 22. Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
    Levy JV
    Am J Med; 1976 Nov; 61(5):779-89. PubMed ID: 10729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison between metroprolol, alprenolol and oxprenolol in the treatment of hypertension.
    Tuomilehto J
    Acta Med Scand Suppl; 1979; 625():74-80. PubMed ID: 373397
    [No Abstract]   [Full Text] [Related]  

  • 24. Adrenergic blocking agents and lipoprotein lipase activity.
    Rubba P; De Simone B; Marotta T; Leccia G; Soro S; Ferrara LA
    J Endocrinol Invest; 1989 Feb; 12(2):119-22. PubMed ID: 2754182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipids and lipoprotein fractions after cyclopenthiazide and oxprenolol: a double-blind crossover study.
    Crisp AJ; Kennedy PG; Hoffbrand BI; Ebbutt AF; Carruthers M
    Curr Med Res Opin; 1980; 7(2):101-3. PubMed ID: 7002477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atenolol and metoprolol: comparison of effects on blood pressure and serum lipoproteins, and side effects.
    Rössner S; Weiner L
    Eur J Clin Pharmacol; 1983; 24(5):573-7. PubMed ID: 6873132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of pindolol and metoprolol on plasma lipids and lipoproteins.
    Pasotti C; Capra A; Fiorella G; Vibelli C; Chierichetti SM
    Br J Clin Pharmacol; 1982; 13(Suppl 2):435S-439S. PubMed ID: 7104157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do beta-blockers alter lipids and what are the consequences?
    Holtzman E; Rosenthal T; Goldbourt U; Segal P
    J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S86-92; discussion S93. PubMed ID: 2481177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensive effect and side-effects of treatment with beta blockers- a comparative study between oxprenolol and propranolol.
    Andersson O; Berglund G; Bergman H; Cramer K; Fagerberg SE; Forsberg SA; Johnsen V; Lundkvist L; Rutle O; Sjolyst R
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):43-50. PubMed ID: 812664
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of indoramin and metoprolol on plasma lipids and lipoproteins.
    Martinez TL; Auriemo CR; Machado AM; Cunha MA; Feres MC; Maldjian S; Wortsman A; Delboni FO
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S76-9. PubMed ID: 2423803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of labetalol and oxprenolol on blood lipids.
    Sommers DK; de Villiers LS; van Wyk M; Schoeman HS
    S Afr Med J; 1981 Sep; 60(10):379-80. PubMed ID: 7025257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of a cardioselective beta-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk.
    Boquist S; Ruotolo G; Hellénius ML; Danell-Toverud K; Karpe F; Hamsten A
    Atherosclerosis; 1998 Apr; 137(2):391-400. PubMed ID: 9622282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of carvedilol and metoprolol on serum lipid concentrations and symptoms in patients with hyperthyroidism.
    Ozbilen S; Eren MA; Turan MN; Sabuncu T
    Endocr Res; 2012; 37(3):117-23. PubMed ID: 22571552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic effects of oxprenolol and propranolol in hypertension.
    Franciosa JA; Johnson SM; Tobian LJ
    Clin Pharmacol Ther; 1979 Dec; 26(6):676-81. PubMed ID: 387330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of chlorthalidone and metoprolol alone or in combination (logroton) on blood pressure, lipids, lipoproteins and circulating plasma ANF levels in essential hypertension.
    Bielmann P; Leduc G; Thibault G; Lepage J; Davignon J
    Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):479-85. PubMed ID: 1839902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Oxprenolol in the treatment of essential arterial hypertension].
    Soto Rojas G
    Prensa Med Mex; 1976; 41(5-6):188-93. PubMed ID: 792867
    [No Abstract]   [Full Text] [Related]  

  • 37. Trial of combination of guanethidine and oxprenolol in hypertension.
    Pearson RM; Bending MR; Bulpitt CJ; George CF; Hole DR; Williams FM; Breckenridge AM
    Br Med J; 1976 Apr; 1(6015):933-6. PubMed ID: 773486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exercise and resting blood pressure and heart rate changes 24 h after dosing in patients with essential hypertension receiving 16/260 oxprenolol Oros once daily.
    Müller FB; Allsopp LF; Cooper GL; Bolli P; Frei P; Glaus L; Ritz R; Bühler FR
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):207S-212S. PubMed ID: 4005124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different effects of metoprolol and chlorthalidone on serum lipoprotein levels in mild hypertension. Possible implications for coronary heart disease risk status.
    Holtzman E; Rosenthal T; Goldbourt U; Segal P
    Isr J Med Sci; 1984 Dec; 20(12):1169-76. PubMed ID: 6519949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in insulin-dependent diabetics.
    Viberti GC; Keen H; Bloom SR
    Metabolism; 1980 Sep; 29(9):873-9. PubMed ID: 6106149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.